erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Asthenia D001247 5 associated lipids
Ataxia D001259 20 associated lipids
Auditory Diseases, Central D001304 2 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Balanitis D001446 4 associated lipids
Bartonella Infections D001474 3 associated lipids
Bile Reflux D001655 2 associated lipids
Birth Weight D001724 23 associated lipids
Bites, Human D001734 2 associated lipids
Blepharitis D001762 4 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Resorption D001862 7 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchopneumonia D001996 7 associated lipids
Bundle-Branch Block D002037 2 associated lipids
Bursitis D002062 3 associated lipids
Campylobacter Infections D002169 13 associated lipids
Carbuncle D002270 1 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Uterine Cervical Erosion D002579 2 associated lipids
Uterine Cervical Incompetence D002581 3 associated lipids
Chancroid D002602 4 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Choanal Atresia D002754 1 associated lipids
Cholelithiasis D002769 16 associated lipids
Cholestasis D002779 23 associated lipids
Choline Deficiency D002796 16 associated lipids
Chorioamnionitis D002821 5 associated lipids
Choroiditis D002833 1 associated lipids
Chronic Disease D002908 7 associated lipids
Cleft Palate D002972 9 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Common Cold D003139 2 associated lipids
Compartment Syndromes D003161 1 associated lipids
Conjunctivitis D003231 7 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Constipation D003248 8 associated lipids
Corneal Diseases D003316 13 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Crohn Disease D003424 12 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dacryocystitis D003607 1 associated lipids
Death, Sudden D003645 12 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diarrhea D003967 32 associated lipids
Diarrhea, Infantile D003968 3 associated lipids
Digestive System Abnormalities D004065 1 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Dry Socket D004368 3 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dysarthria D004401 2 associated lipids
Dysentery, Bacillary D004405 6 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Edema D004487 152 associated lipids
Elephantiasis D004604 2 associated lipids
Empyema D004653 3 associated lipids
Endocarditis D004696 4 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Oyarzún E et al. Antibiotic treatment in preterm labor and intact membranes: a randomized, double-blinded, placebo-controlled trial. 1998 May-Jun J Matern Fetal Med pmid:9642605
Shimatani T Involvement of cholinergic motor neurons in pharmacological regulation of gastrointestinal motility by glucagon in conscious dogs. 1997 Aug-Oct J Smooth Muscle Res pmid:9639019
Havlik J and Holý M [Erythromycin stearate Spofa--coated tablets for pediatric practice]. 1976 Cesk Pediatr pmid:963828
Novaes AB et al. Immediate implants placed into infected sites: a histomorphometric study in dogs. 1998 May-Jun Int J Oral Maxillofac Implants pmid:9638015
Stassi DL et al. Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9636144
Wandel C et al. Effect of CYP3A inhibition on vesnarinone metabolism in humans. 1998 Clin. Pharmacol. Ther. pmid:9630823
Wirsing von König CH et al. Factors influencing the spread of pertussis in households. 1998 Eur. J. Pediatr. pmid:9625336
Souli M et al. In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. 1998 Int. J. Antimicrob. Agents pmid:9624540
Roblin PM and Hammerschlag MR In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9624507
Reinert RR et al. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. 1998 Antimicrob. Agents Chemother. pmid:9624505
Kataja J et al. Different erythromycin resistance mechanisms in group C and group G streptococci. 1998 Antimicrob. Agents Chemother. pmid:9624500
Muli F and Struthers JK Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. 1998 Antimicrob. Agents Chemother. pmid:9624489
Rosato A et al. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. 1998 Antimicrob. Agents Chemother. pmid:9624482
Widdowson CA and Klugman KP Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. 1998 Apr-Jun Emerging Infect. Dis. pmid:9621199
Kruppa A et al. Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. 1998 Dermatology (Basel) pmid:9621142
Kudoh S et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. 1998 Am. J. Respir. Crit. Care Med. pmid:9620913
Krone LV The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. 1998 WMJ pmid:9617308
Syphilis--recommended treatment schedules, 1976. 1976 Am Fam Physician pmid:961559
Bourrat E et al. [Rosacea with ocular involvement in a child]. 1996 Ann Dermatol Venereol pmid:9615130
Mathis C and Malbert CH Changes in pyloric resistance induced by erythromycin. 1998 Neurogastroenterol. Motil. pmid:9614671
Gaisser S et al. Analysis of eryBI, eryBIII and eryBVII from the erythromycin biosynthetic gene cluster in Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9613575
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
Kudoh S Erythromycin treatment in diffuse panbronchiolitis. 1998 Curr Opin Pulm Med pmid:9612675
Paesen J et al. Study of the stability of erythromycin in a hydrophilic creme basis by liquid chromatography. 1998 J Pharm Biomed Anal pmid:9608426
Vachálková A and Novotný L Polarographic testing of carcinogenicity of some chemotherapeutics. 1997 Neoplasma pmid:9605013
Farrell AM et al. Pyoderma gangrenosum of the penis. 1998 Br. J. Dermatol. pmid:9602887
Karrer S et al. [Acne comedonica following radiation therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9601475
Ng P et al. Diffuse panbronchiolitis: case report and review of the literature. 1998 Australas Radiol pmid:9599832
Muranaka H et al. [Superoxide radical scavenging activity of an erythromycin-iron complex (the second report)]. 1998 Jpn J Antibiot pmid:9597516
Tanabe O et al. [Mechanism of erythromycin action on gene expression of airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597514
Kyo S et al. [Effects of macrolides on intracellular Ca2+ response by airway epithelium]. 1998 Jpn J Antibiot pmid:9597513
Nakada M et al. [Inhibitory effects of macrolide antibiotics at low concentrations on vero toxin production by pathogenic E. coli O157]. 1998 Jpn J Antibiot pmid:9597511
Kozeki S et al. [Study on bacterial biofilm destruction by various antibacterial agents]. 1998 Jpn J Antibiot pmid:9597510
Yoshimine H et al. [Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain]. 1998 Jpn J Antibiot pmid:9597508
Sugiyama Y et al. [Changes in cytokine production by pulmonary alveolar macrophages collected from rats that have been treated with erythromycin for an extended period]. 1998 Jpn J Antibiot pmid:9597506
Abe S et al. [Effect of macrolides on IL-8 gene expression by cultured airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597504
Nishimura J et al. [Effects of erythromycin on Pseudomonas aeruginosa pyocyanine-induced IL-8 production and its biological activity (the 2nd report)]. 1998 Jpn J Antibiot pmid:9597503
Okura M et al. [Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature Infants]. 1998 Jpn J Antibiot pmid:9597500
Miyazawa T et al. [Mucous pathology and macrolide treatment of paranasal sinusitis in children]. 1998 Jpn J Antibiot pmid:9597499
Kishi K et al. [Study of efficacy of macrolide therapy applied to Kartagener's syndrome]. 1998 Jpn J Antibiot pmid:9597497
Shirai R et al. [Evaluation of the duration of medication with erythromycin for treatment of diffuse panbronchitis--a comparison between interruption of medication and continued administration]. 1998 Jpn J Antibiot pmid:9597496
Nakada K et al. [Therapeutic guideline for diffuse panbronchitis (draft). Subcommittee on Diffuse Lung Diseases, Research Committee on Respiratory Diseases Organized by the Ministry of Health and Welfare]. 1998 Jpn J Antibiot pmid:9597494
Kawasaki S et al. [Effects of a steroid and macrolide antibiotic on adhesion of neutrophils to the airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597483
Takeda H et al. [Bone absorption suppression by broad spectrum antibiotics]. 1998 Jpn J Antibiot pmid:9597475
Tamaoki J et al. [Effects of macrolide antibiotics on iNOS gene expression and NO production by alveolar macrophages]. 1998 Jpn J Antibiot pmid:9597474
Hikariyama T et al. [Study of suppression of neutrophil functions and prevention of vascular endothelial injury by macrolide antibiotics]. 1998 Jpn J Antibiot pmid:9597473
Hori S et al. [Effects of macrolide drugs on endogenous glucocorticoids]. 1997 Jpn J Antibiot pmid:9597471
Nonaka M et al. [Effects of macrolide antibiotics on fibroblasts]. 1997 Jpn J Antibiot pmid:9597470
Miyashima S et al. [Effects of erythromycin on a mouse hypersensitivity pneumonia model]. 1997 Jpn J Antibiot pmid:9597469
Kaseta M et al. [Study of therapeutic effects of macrolide antibiotics on patients with anti-HTLV-1 antibody positive DPB (diffuse panbronchitis)]. 1997 Jpn J Antibiot pmid:9597466
Takada T et al. [Study of specific mRNA expression by peripheral monocytes of patients with diffuse panbronchitis using cDNA representational difference analysis (RDA)]. 1997 Jpn J Antibiot pmid:9597465
Hoshina S et al. [C kinase activation and induction of HL 60 promyelocytic leukemia cell differentiation caused by roxithromycin]. 1997 Jpn J Antibiot pmid:9597464
Tei A et al. [Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes]. 1997 Jpn J Antibiot pmid:9597458
Kudo S [Preliminary survey on DPB (diffuse panbronchitis) in Japan and a survey on the status of DPB in China]. 1997 Jpn J Antibiot pmid:9597457
Kondo K et al. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597456
Kobayashi O et al. [Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597455
Ohara K et al. [Effects of pretreatment by erythromycin or rokitamycin on aminoglycoside inactivating enzyme of Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597454
Sato K et al. [Pyocyanine synthesis by Pseudomonas aeruginosa in chronic airway infection and the effect of erythromycin on its biological activity]. 1997 Jpn J Antibiot pmid:9597453
Mineshita M et al. [Effect of macrolide antibiotics on actin polymerization reactions of neutrophils]. 1997 Jpn J Antibiot pmid:9597447
Kawasaki S et al. [Effects of a steroid and macrolide antibiotic on IL-8 production by neutrophils]. 1997 Jpn J Antibiot pmid:9597446
Suzuki H et al. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics]. 1997 Jpn J Antibiot pmid:9597442
Nakada J et al. [Effects of erythromycin and roxithromycin on airway goblet cell secretion]. 1997 Jpn J Antibiot pmid:9597441
Ieshiro R et al. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer]. 1997 Jpn J Antibiot pmid:9597440
Sakata K et al. [Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation]. 1997 Jpn J Antibiot pmid:9597435
Hoover J "Antibiotic selection for endodontic infections". 1995 J Gt Houst Dent Soc pmid:9594808
de Bethune MP and Nierhaus KH Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes. 1978 Eur. J. Biochem. pmid:95947
Dodhia H and Miller E Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. 1998 Epidemiol. Infect. pmid:9593483
Spangler SK et al. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. 1998 Antimicrob. Agents Chemother. pmid:9593160
Goldstein EJ et al. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. 1998 Antimicrob. Agents Chemother. pmid:9593139
Wieteska M [Legionnaires' diseases]. 1998 Pol. Merkur. Lekarski pmid:9591446
Boiron M et al. Erythromycin elicits opposite effects on antro-bulbar and duodenal motility: analysis in diabetics by cineradiography. 1997 Arch. Physiol. Biochem. pmid:9587651
Bertho G et al. Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. 1998 Int. J. Biol. Macromol. pmid:9585888
Bouvier d'Yvoire MJ et al. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. 1998 J. Antimicrob. Chemother. pmid:9579715
Malizia T et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. 1998 J. Antimicrob. Chemother. pmid:9579710
Brett M et al. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis. 1998 J. Antimicrob. Chemother. pmid:9579709
Ednie LM et al. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. 1998 J. Antimicrob. Chemother. pmid:9578166
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Hoppe JE Susceptibility testing of Bordetella pertussis. 1998 J. Clin. Microbiol. pmid:9574735
Higa F et al. Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. 1998 J. Clin. Microbiol. pmid:9574712
Piccolomini R et al. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. 1997 Oral Microbiol. Immunol. pmid:9573812
Stephenson GA et al. Formation of isomorphic desolvates: creating a molecular vacuum. 1998 J Pharm Sci pmid:9572901
Griesgraber G et al. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572891
Elliott RL et al. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572890
Juanqin G et al. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. 1998 Mar-Apr Pediatr Dermatol pmid:9572705
Roark GA Guest clinician: an alternative treatment of RAU (recurrent apthous ulcers). 1996 Miss Dent Assoc J pmid:9571920
Andrews PA Interactions with ciprofloxacin and erythromycin leading to aminophylline toxicity. 1998 Nephrol. Dial. Transplant. pmid:9568870
Riley RJ and Howbrook D In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. 1997 J Pharmacol Toxicol Methods pmid:9566442
Delgado LF et al. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. 1998 Ann. Allergy Asthma Immunol. pmid:9564984
Jamkhedkar PP et al. Clinico-epidemiologic features of granuloma inguinale in the era of acquired immune deficiency syndrome. 1998 Sex Transm Dis pmid:9564722
Salah-Bey K et al. Targeted gene inactivation for the elucidation of deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9563840
Kieran E et al. Group B streptococcus (GBS) colonisation among expectant Irish mothers. 1998 Jan-Feb Ir Med J pmid:9563251
Mitsuyama T et al. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. 1998 Mol. Cell. Biochem. pmid:9562252
Garcia-Bermejo I et al. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. 1998 Antimicrob. Agents Chemother. pmid:9559831
Hoppe JE and Bryskier A In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). 1998 Antimicrob. Agents Chemother. pmid:9559823
Roblin PM and Hammerschlag MR In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9559818
Barry AL et al. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). 1998 Antimicrob. Agents Chemother. pmid:9559816
Rutman A et al. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. 1998 Antimicrob. Agents Chemother. pmid:9559781
Cleary RK et al. Metronidazole may inhibit intestinal colonization with Clostridium difficile. 1998 Dis. Colon Rectum pmid:9559631
Ross JI et al. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. 1998 Dermatology (Basel) pmid:9557230
Shah F Erythromycin. 1998 Pediatr Rev pmid:9557068